Determining the best approach to reduce the impact of exercise-induced atrial fibrillation: prevention, screening, or symptom-based treatment?

References

• Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34:1061–1067.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998;98:946–952.
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation : 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359–364.
   PubMed Web of Science ®Google Scholar
• Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34:2746–2751.
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study. Lancet. 2015;386:154–162.
   PubMed Web of Science ®Google Scholar
• Sanna T, Diener H-C, Passman RS, et al. Cryptogenic stroke and atrial fibrillation. N Engl J Med. 2014;371:1261.
   PubMedGoogle Scholar
• Kishore A, Vail A, Majid A, et al. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke. 2014;45:520–526.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation. 2003;107:2920–2925.
   PubMed Web of Science ®Google Scholar
• Calvo N, Ramos P, Montserrat S, et al. Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study. Europace. 2016;18:57–63.
   PubMed Web of Science ®Google Scholar
• Lau DH, Nattel S, Kalman JM, et al. Modifiable risk factors and atrial fibrillation. Circulation. 2017;136:583–596.
   PubMed Web of Science ®Google Scholar
• Mont L, Sambola A, Brugada J, et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J. 2002;23:477–482.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
   PubMed Web of Science ®Google Scholar
• Sattelmair J, Pertman J, Ding EL, et al. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation. 2011;124:789–795.
   PubMed Web of Science ®Google Scholar
• Pandey A, Garg S, Khunger M, et al. Dose-response relationship between physical activity and risk of heart failure: a meta-analysis. Circulation. 2015;132:1786–1794.
   PubMed Web of Science ®Google Scholar
• Lee D, Pate RR, Lavie CJ, et al. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol. 2014;64:472–481.
   PubMed Web of Science ®Google Scholar
• Raju H, Kalman JM. Management of atrial fibrillation in the athlete. Heart Lung Circ. 2018;27:1086–1092.
   PubMed Web of Science ®Google Scholar
• Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11:1156–1159.
   PubMed Web of Science ®Google Scholar
• Nielsen JR, Wachtell K, Abdulla J. The relationship between physical activity and risk of atrial fibrillation-a systematic review and meta-analysis. J Atr Fibrillation. 2013;5:789.
   PubMedGoogle Scholar
• Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66:2343–2349.
   PubMed Web of Science ®Google Scholar
• Karjalainen J, Kujala UM, Kaprio J, et al. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ. 1998;316:1784–1785.
   PubMed Web of Science ®Google Scholar
• Grimsmo J, Grundvold I, Maehlum S, et al. High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors–a 28-30 years follow-up study. Eur J Cardiovasc Prev Rehabil. 2010;17:100–105.
   PubMedGoogle Scholar
• Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008;29:71–78.
   PubMed Web of Science ®Google Scholar
• Molina L, Mont L, Marrugat J, et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace. 2008;10:618–623.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Jakicic JM, Ard JD, et al. AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2013;63:2960–2984.
   PubMed Web of Science ®Google Scholar
• Guasch E, Nattel S. CrossTalk proposal: prolonged intense exercise training does lead to myocardial damage. J Physiol. 2013;591:4939–4941.
   PubMed Web of Science ®Google Scholar
• Carpenter A, Frontera A, Bond R, et al. Vagal atrial fibrillation: what is it and should we treat it? Int J Cardiol. 2015;201:415–421.
   PubMed Web of Science ®Google Scholar
• Guasch E, Mont L. Diagnosis, pathophysiology, and management of exercise-induced arrhythmias. Nat Rev Cardiol. 2017;14:88–101.
   PubMed Web of Science ®Google Scholar
• Guasch E, Benito B, Qi X, et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol. 2013;62:68–77.
   PubMed Web of Science ®Google Scholar
• Brugger N, Krause R, Carlen F, et al. Effect of lifetime endurance training on left atrial mechanical function and on the risk of atrial fibrillation. Int J Cardiol. 2014;170:419–425.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Sharma S, Boyett MR. CrossTalk opposing view: bradycardia in the trained athlete is attributable to a downregulation of a pacemaker channel in the sinus node. J Physiol. 2015;593:1749–1751.
   PubMed Web of Science ®Google Scholar
• Shen MJ, Choi E, Tan AY, et al. Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol. 2012;9:30–39.
   Web of Science ®Google Scholar
• Wilhelm M, Nuoffer J-M, Schmid J-P, et al. Comparison of pro-atrial natriuretic peptide and atrial remodeling in marathon versus non-marathon runners. Am J Cardiol. 2012;109:1060–1065.
   PubMed Web of Science ®Google Scholar
• Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46:690–696.
   PubMed Web of Science ®Google Scholar
• Aschar-Sobbi R, Izaddoustdar F, Korogyi AS, et al. Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα. Nat Commun. 2015;6:6018.
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Zueger T, De Marchi S, et al. Inflammation and atrial remodeling after a mountain marathon. Scand J Med Sci Sports. 2014;24:519–525.
   PubMed Web of Science ®Google Scholar
• Oláh A, Németh BT, Mátyás C, et al. Cardiac effects of acute exhaustive exercise in a rat model. Int J Cardiol. 2015;182:258–266.
   PubMed Web of Science ®Google Scholar
• Guo Y, Lip GYH, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60:2263–2270.
   PubMed Web of Science ®Google Scholar
• Mont L, Tamborero D, Elosua R, et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace. 2008;10:15–20.
   PubMed Web of Science ®Google Scholar
• Crump C, Sundquist J, Winkleby MA, et al. Height, weight, and aerobic fitness level in relation to the risk of atrial fibrillation. Am J Epidemiol. 2018;187:417–426.
   PubMed Web of Science ®Google Scholar
• Guasch E, Mont L, Sitges M. Mechanisms of atrial fibrillation in athletes: what we know and what we do not know. Netherlands Heart J. 2018;26:133–145.
   PubMed Web of Science ®Google Scholar
• Elliott AD, Linz D, Verdicchio CV, et al. Exercise and atrial fibrillation: prevention or causation? Heart Lung Circ. 2018;27:1078–1085.
   PubMed Web of Science ®Google Scholar
• Morseth B, Graff-Iversen S, Jacobsen BK, et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromsø study. Eur Heart J. 2016;37:2307–2313.
   PubMed Web of Science ®Google Scholar
• Khan H, Kella D, Rauramaa R, et al. Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study. Heart Rhythm. 2015;12:1424–1430.
   PubMed Web of Science ®Google Scholar
• Brignole M, European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European society of cardiology (ESC). Developed in collaboration with the European heart rhythm association. Europace. 2013;15:1070–1118.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Furberg CD, Psaty BM, et al. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2008;118:800–807.
   PubMed Web of Science ®Google Scholar
• Aizer A, Gaziano JM, Cook NR, et al. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol. 2009;103:1572–1577.
   PubMed Web of Science ®Google Scholar
• Elosua R, Arquer A, Mont L, et al. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol. 2006;108:332–337.
   PubMed Web of Science ®Google Scholar
• Drca N, Wolk A, Jensen-Urstad M, et al. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart. 2014;100:1037–1042.
   PubMed Web of Science ®Google Scholar
• Andersen K, Farahmand B, Ahlbom A, et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J. 2013;34:3624–3631.
   PubMed Web of Science ®Google Scholar
• Andersen K, Rasmussen F, Held C, et al. Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study. BMJ. 2015;351:h4543.
   PubMed Web of Science ®Google Scholar
• Mohanty S, Mohanty P, Tamaki M, et al. Differential association of exercise intensity with risk of atrial fibrillation in men and women: evidence from a meta-analysis. J Cardiovasc Electrophysiol. 2016;27:1021–1029.
   PubMed Web of Science ®Google Scholar
• Myrstad M, Aarønæs M, Graff-Iversen S, et al. Does endurance exercise cause atrial fibrillation in women? Int J Cardiol. 2015;184:431–432.
   PubMed Web of Science ®Google Scholar
• Guasch E, Mont L. Exercise, sex and atrial fibrillation: arrhythmogenesis beyond Y-chromosome? Heart. 2015;101:1607–1609.
   PubMed Web of Science ®Google Scholar
• Drca N, Wolk A, Jensen-Urstad M, et al. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart. 2015;101:1627–1630.
   PubMed Web of Science ®Google Scholar
• Fenger-Grøn M, Overvad K, Tjønneland A, et al. Lean body mass is the predominant anthropometric risk factor for atrial fibrillation. J Am Coll Cardiol. 2017;69:2488–2497.
   PubMed Web of Science ®Google Scholar
• Otway R, Vandenberg JI, Guo G, et al. Stretch-sensitive KCNQ1 mutation. A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol. 2007;49:578–586.
   PubMed Web of Science ®Google Scholar
• Nattel S, Guasch E, Savelieva I, et al. Early management of atrial fibrillation to prevent cardiovascular complications. Eur Heart J. 2014;35:1448–1456.
   PubMed Web of Science ®Google Scholar
• Freedman B, Camm J, Calkins H, et al. Screening for atrial fibrillation. Circulation. 2017;135:1851–1867.
   PubMed Web of Science ®Google Scholar
• Mairesse GH, Moran P, Van Gelder IC, et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and sociedad latinoamericana de Estimulación Cardíaca y Electrofisiolog. Europace. 2017;19:1589–1623.
   PubMed Web of Science ®Google Scholar
• Kotecha D, Breithardt G, Camm AJ, et al. Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA consensus conference. Europace. 2018;20:395–407.
   PubMed Web of Science ®Google Scholar
• Steinhubl SR, Waalen J, Edwards AM, et al. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA. 2018;320:146–155.
   PubMed Web of Science ®Google Scholar
• Healey JS, Alings M, Ha A, et al. Subclinical atrial fibrillation in older patients. Circulation. 2017;136:1276–1283.
   PubMed Web of Science ®Google Scholar
• Hoogsteen J, Schep G, Van Hemel NM, et al. Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. Europace. 2004;6:222–228.
   PubMed Web of Science ®Google Scholar
• Taggar JS, Coleman T, Lewis S, et al. Accuracy of methods for diagnosing atrial fibrillation using 12-lead ECG: a systematic review and meta-analysis. Int J Cardiol. 2015;184:175–183.
   PubMed Web of Science ®Google Scholar
• Fung E, Järvelin M-R, Doshi RN, et al. Electrocardiographic patch devices and contemporary wireless cardiac monitoring. Front Physiol. 2015;6:149.
   PubMed Web of Science ®Google Scholar
• Caminal P, Sola F, Gomis P, et al. Validity of the polar V800 monitor for measuring heart rate variability in mountain running route conditions. Eur J Appl Physiol. 2018;118:669–677.
   PubMed Web of Science ®Google Scholar
• Jaakkola J, Jaakkola S, Lahdenoja O, et al. Mobile phone detection of atrial fibrillation with mechanocardiography: the MODE-AF study (Mobile phone detection of atrial fibrillation). Circulation. 2018;137:1524–1527.
   PubMed Web of Science ®Google Scholar
• Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111:1167–1176.
   PubMed Web of Science ®Google Scholar
• Lowres N, Krass I, Neubeck L, et al. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation. Int J Clin Pharm. 2015;37:1111–1120.
   PubMed Web of Science ®Google Scholar
• Chan N-Y, Choy -C-C. Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram. Heart. 2017;103:24–31.
   PubMed Web of Science ®Google Scholar
• Svennberg E, Engdahl J, Al-Khalili F, et al. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation. 2015;131:2176–2184.
   PubMed Web of Science ®Google Scholar
• Chan P-H, Wong C-K, Pun L, et al. Head-to-Head comparison of the alivecor heart monitor and microlife WatchBP office AFIB for atrial fibrillation screening in a primary care setting. Circulation. 2017;135:110–112.
   PubMedGoogle Scholar
• Chan N-Y, Choy -C-C, Chan C-K, et al. Effectiveness of a nongovernmental organization-led large-scale community atrial fibrillation screening program using the smartphone electrocardiogram: an observational cohort study. Hear Rhythm. 2018;15:1306-1311.
   Web of Science ®Google Scholar
• Chan P-H, Wong C-K, Poh YC, et al. Diagnostic performance of a smartphone-based photoplethysmographic application for atrial fibrillation screening in a primary care setting. J Am Heart Assoc. 2016;5:e003428.
   PubMed Web of Science ®Google Scholar
• Kao W-F, Hou S-K, Huang C-Y, et al. Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: an unblinded clinical trial. PLoS One. 2018;13:e0198852.
   PubMed Web of Science ®Google Scholar
• Sanna GD, Gabrielli E, De Vito E, et al. Atrial fibrillation in athletes: from epidemiology to treatment in the novel oral anticoagulants era. J Cardiol. 2018;72:269–276.
   PubMedGoogle Scholar
• Elliott AD, Mahajan R, Lau DH, et al. Atrial fibrillation in endurance athletes: from mechanism to management. Cardiol Clin. 2016;34:567–578.
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Roten L, Tanner H, et al. Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes. Am J Cardiol. 2011;108:580–585.
   PubMed Web of Science ®Google Scholar
• Wilhelm M, Roten L, Tanner H, et al. Long-term cardiac remodeling and arrhythmias in nonelite marathon runners. Am J Cardiol. 2012;110:129–135.
   PubMed Web of Science ®Google Scholar
• Scott CC, C V L, Kilman JW, et al. The effect of left atrial histology and dimension on P wave morphology. J Electrocardiol. 1983;16:363–366.
   PubMed Web of Science ®Google Scholar
• Petersson R, Berge HM, Gjerdalen GF, et al. P-wave morphology is unaffected by atrial size: a study in healthy athletes. Ann Noninvasive Electrocardiol. 2014;19:366–373.
   PubMed Web of Science ®Google Scholar
• Il IS, Park DH, Kim BJ, et al. Clinical and electrocardiographic characteristics for prediction of new-onset atrial fibrillation in asymptomatic patients with atrial premature complexes. Int J Cardiol Heart Vasc. 2018;19:70–74.
   PubMed Web of Science ®Google Scholar
• Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest. 1982;81:302–307.
   PubMed Web of Science ®Google Scholar
• Elliott AD, Mahajan R, Linz D, et al. Atrial remodeling and ectopic burden in recreational athletes: implications for risk of atrial fibrillation. Clin Cardiol. 2018;41:843–848.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Bucchi A, Johnsen AB, et al. Exercise training reduces resting heart rate via downregulation of the funny channel HCN4. Nat Commun. 2014;5:3775.
   PubMed Web of Science ®Google Scholar
• Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802–809.
   PubMed Web of Science ®Google Scholar
• Benito EM, Carlosena-Remirez A, Guasch E, et al. Left atrial fibrosis quantification by late gadolinium-enhanced magnetic resonance: a new method to standardize the thresholds for reproducibility. Europace. 2017;19:1272–1279.
   PubMed Web of Science ®Google Scholar
• Cameli M, Lisi M, Righini FM, et al. Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. 2013;111:595–601.
   PubMed Web of Science ®Google Scholar
• Swartz MF, Fink GW, Sarwar MF, et al. Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. J Am Coll Cardiol. 2012;60:1799–1806.
   PubMed Web of Science ®Google Scholar
• Lindsay MM, Dunn FG. Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Br J Sports Med. 2007;41:447–452.
   PubMed Web of Science ®Google Scholar
• Roca E, Nescolarde L, Lupón J, et al. The dynamics of cardiovascular biomarkers in non-elite marathon runners. J Cardiovasc Transl Res. 2017;10:206–208.
   PubMed Web of Science ®Google Scholar
• Baggish AL, Hale A, Weiner RB, et al. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol. 2011;589:3983–3994.
   PubMed Web of Science ®Google Scholar
• Mont L, Pelliccia A, Sharma S, et al. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Europace. 2017;19:139–163.
   PubMed Web of Science ®Google Scholar
• Hobbs FDR, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005;9:iii–iv,ix–x, 1–74.
   PubMed Web of Science ®Google Scholar
• Aronsson M, Svennberg E, Rosenqvist M, et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace. 2015;17:1023–1029.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation. 2004;110:1042–1046.
   PubMed Web of Science ®Google Scholar
• Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311:498–506.
   PubMed Web of Science ®Google Scholar
• Berruezo A, Tamborero D, Mont L, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J. 2007;28:836–841.
   PubMedGoogle Scholar
• Bunch TJ, May HT, Bair TL, et al. Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes. Hear Rhythm. 2013;10:1257–1262.
   PubMed Web of Science ®Google Scholar
• de Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010;55:725–731.
   PubMed Web of Science ®Google Scholar
• Lip GYHH, Laroche C, Dan GAG-A, et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) pilot general registry. Europace. 2014;16:308–319.
   PubMed Web of Science ®Google Scholar
• Heidbüchel H, Panhuyzen-Goedkoop N, Corrado D, et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil. 2006;13:475–484.
   PubMedGoogle Scholar
• Krishnamoorthy S, Lip GYH, Lane DA. Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review. Am J Med. 2009;122:851–856.e3.
   PubMed Web of Science ®Google Scholar
• Sciarra L, Rebecchi M, De Ruvo E, et al. How many atrial fibrillation ablation candidates have an underlying supraventricular tachycardia previously unknown? Efficacy of isolated triggering arrhythmia ablation. Europace. 2010;12:1707–1712.
   PubMed Web of Science ®Google Scholar
• Giustetto C, Cerrato N, Gribaudo E, et al. Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis. Hear Rhythm. 2014;11:259–265.
   PubMed Web of Science ®Google Scholar
• Flannery MD, Kalman JM, Sanders P, et al. State of the art review: atrial fibrillation in athletes. Heart Lung Circ. 2017;26:983–989.
   PubMed Web of Science ®Google Scholar
• Heidbüchel H, Anné W, Willems R, et al. Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter. Int J Cardiol. 2006;107:67–72.
   PubMed Web of Science ®Google Scholar
• Furlanello F, Bertoldi A, Dallago M, et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol. 1998;9:S63–S68.
   PubMed Web of Science ®Google Scholar
• Boucher M, Chassaing C, Herbet A, et al. Interactions with the cardiac cholinergic system: effects of disopyramide and its mono-N-dealkylated metabolite. Life Sci. 1992;50:PL161–PL166.
   PubMed Web of Science ®Google Scholar
• Myrstad M, Vegard M, Ulimoen SR, et al. Exercise in individuals with atrial fibrillation. Clin Res Cardiol. 2018.  doi: 10.1007/s00392-018-1361-9.
   PubMedGoogle Scholar
• Calvo N, Mont L, Tamborero D, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace. 2010;12:30–36.
   PubMed Web of Science ®Google Scholar
• Koopman P, Nuyens D, Garweg C, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011;13:1386–1393.
   PubMed Web of Science ®Google Scholar
• Furlanello F, Lupo P, Pittalis M, et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol. 2008;19:457–462.
   PubMed Web of Science ®Google Scholar
• Sussman S, Lisha N, Griffiths M. Prevalence of the addictions: a problem of the majority or the minority? Eval Health Prof. 2011;34:3–56.
   PubMed Web of Science ®Google Scholar
• Fabritz L, Guasch E, Antoniades C, et al. Expert consensus document: defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol. 2016;13:230–237.
   PubMed Web of Science ®Google Scholar